Can you implement the best science-, risk-, and statistics-based approaches to cleaning validation? Today’s regulators are now expecting HBEL monographs and comprehensive risk assessments of your organization’s cleaning validation program. Pharma Ed’s Cleaning Validation Summit brings together leading industry experts to illuminate best practices, help you meet regulatory requirements, and provide practical insights into avoiding costly mistakes.

Now celebrating its 10th year, the Festival has long been the annual get-together for the UK genomics community. And with more speakers and sessions than ever before, the 2025 edition is bigger and better than ever!

As the genomics sector has expanded, so has its impact. The Festival now covers a diverse array of topics beyond genomics, including biodata, diagnostics, cancer research, healthcare, drug discovery and development, infectious diseases, AI, proteomics, multi-omics, single-cell & spatial analysis and so much more. Which means that if you work in any area of life sciences, there’s almost certainly something for you.

Waves of new models are being validated. A wider industry shift to precision oncology is requiring more specific genetic models. Availability and cost-effectiveness of sequencing and computational tools are enabling better and more accessible characterization of therapeutic pathways than ever before. The challenges and opportunities in preclinical and translational research are constantly evolving, and it has never been more critical to benchmark and share cross-industry learnings and case studies to de-risk the move to the clinic.

Returning in 2025, the 3rd Spatial Biology for Immuno-Oncology Summit offers a unique platform for you and your peers to address the industry's most pressing challenges. Engage with global experts from Pathology, Computational Biology, Bioinformatics, and Translation to uncover practical case studies that showcase the successful application of spatial biology in immuno-oncology.

The WCBP Scientific Organizing Committee, which includes individuals representing industry, academia, and regulatory agencies, is looking forward to welcoming everyone. From first-time attendees to those who have attended in previous years, WCBP 2025 will offer something for everyone, including the chance to reconnect with colleagues or make new networks.

With the first LBP approvals on the horizon, but financial pressures threatening to slow progress, the 9th Microbiome Movement Summit Europe returns to Barcelona this January as the essential industry hub for R&D and business leaders determined to push the field forward.

The 3rd Ophthalmic Drug Delivery Summit is an intimate industry-focused forum centred on spearheading ophthalmic device and formulation development. This meeting is your one-stop-shop to gather key updates on cutting-edge technologies, ophthalmic pharmacology and to compare routes of administration capabilities to overcome anatomical barriers, enhance bioavailability, and improve patient outcomes.

The 8th Annual DDR Inhibitors Summit, returning to Boston this January, is the community hotspot for biopharma drug developers and researchers to collaborate on advancing DDR therapeutics.

Join 100+ experts from discovery, preclinical, translational, regulatory, and clinical roles as they unite to harness the potential of DDR inhibitors for cancer treatment and enhance patient outcomes.

The 3rd Molecular Glue Drug Development Summit returns as the only industry-dedicated forum bringing together 90+ experts as they showcase the latest advancements and breakthroughs in molecular glue drug development through discussions and data-driven case studies on screening tools, novel mechanisms of actions of proximity-based degrading and non-degrading molecular glues and lead optimization strategies, to streamline discovery and development of safe and effective glues.

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets, never-before-seen pre-clinical and clinical data, and demonstrating key routes to commercial success for mRNA therapy and vaccine R&D pipelines.

The 6th RNAi-Based Therapeutics Summit is returning to Boston to showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools to assist payload design, and breakthrough chemical modifications which enhance stability, allowing for precise therapeutic delivery.

The 2025 ISPE Facilities of the Future Conference brings together pharmaceutical industry stakeholders, particularly those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.

The European market is capturing 30% of the global medical device field driven by rapid advances in innovative software, AI, and ML. But as medical device developers are met with tedious submission processes, ever-changing software patches, and red tape at every turn, it has never been more important to break out of cross-functional silos and stay two steps ahead of compliance guidelines.

SLAS is ready to create another record-setting conference and exhibition that celebrates the interconnectivity of technology and discovery, laboratory automation, innovation and analytics. We bring all of it under one roof – the researchers, the technology providers, the startups, the leaders, the science, the technology.

With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.

Launched in 1997, Pharmapack is the leading European event for Pharmaceutical Packaging, Drug Delivery, Medical Devices and Machinery. In the past 25+ years, the event has grown from a conference with a small table-top exhibition, to an event hosting 300+ exhibitors and welcoming attendees from 75 different countries.

Advanced Therapies Week has been the epicenter of the cell & gene therapy revolution, a dynamic and must-attend forum where breakthrough technologies and impactful partnerships come to life to transform drug development.

This January, join over 450 industry experts as we dive deep into the most pressing challenges and innovations in contentious IP law.

Across three days of focused discussions and networking, you’ll gain valuable insights into the latest case law, regulatory updates, and strategic litigation approaches, while connecting with key stakeholders who drive the future of life sciences IP.

This prestigious event will bring together industry leaders, experts, and professionals from around the globe to discuss the latest trends, innovations, and best practices in cleanroom design and engineering.

With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.

Kick off 2025 and set the tone for the year at SAE Media Group's 17th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January to unite leaders from the industry, bringing you the latest advances in the combination product drug delivery space and the chance to collaborate across a 3 day programme.

This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Join us at PepTalk, the premier conference dedicated to advancing biotherapeutic discovery and development. With over two decades of experience, PepTalk provides comprehensive programming and innovative solutions that bridge biotherapeutic research and practical application.

Antibody Engineering & Therapeutics is the global meeting place for antibody science, technology and networking, bringing you the latest antibody science, technologies and partners needed to accelerate next generation antibodies towards commercial success. The Antibody Society members are responsible for designing the scientific program and act as the session Chairs.

For over 30 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs.

Cell Bio 2024, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), will showcase a diverse global community of the brightest minds in cell biology. Come network with scientists, present research, explore the exhibit hall, and learn the latest in science and technology focusing on cell biology as the fundamental basis of biology as well as emerging interdisciplinary topics.

The Drug Delivery to the Lungs Conference (DDL) is in it’s 35th year and attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event. DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

The complement community is shifting gear, with more companies than ever targeting alternative complement proteins for their therapies, allowing for a larger range of diseases to be targeted.

With more assets in ophthalmology, neurology, and oncology than ever before, the complement-based therapeutics field has everyone asking the same question: which inhibitor will be the next to harness the complement system for the development of groundbreaking therapies?

From the discovery of new pathways to target to post-approval indication expansion, the immunology landscape is primed to capitalize on the huge strides being taken in achieving efficacy and approving the safety profile of complement-based therapeutics.

Join 100+ complement industry leaders, scientists, and clinicians at the premier, end-to-end 8th Complement-Based Drug Development Summit to shape the future of complement-targeted therapies.

The 7th Annual RNA-Targeted Drug Discovery & Development Summit returns to Boston this December. Increase your knowledge of RNA tertiary structures, delve into innovative preclinical modelling strategies and identify optimal chemical features for advancing specific, efficacious and safe small molecules.

Unite with 100+ RNA Science, Medicinal Chemistry, Structural Biology & Biophysics experts from the likes of AstraZeneca, Sanofi, Novartis, PTC Therapeutics, ReviR Therapeutics, Rgenta Therapeutics, Accent Therapeutics and more at the most comprehensive and definitive event for the community, the 7th RNA-Targeted Drug Discovery & Development Summit, to accomplish faster and smoother translation of RNA targeted therapies towards the clinic.